These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Failure of topical 0.1% alitretinoin gel for classic Kaposi sarcoma: first European experience. Rongioletti F; Zaccaria E; Viglizzo G Br J Dermatol; 2006 Oct; 155(4):856-7. PubMed ID: 16965450 [No Abstract] [Full Text] [Related]
6. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070 [TBL] [Abstract][Full Text] [Related]
7. [Antineoplastic chemotherapy in patients with HIV infection]. Spina M; Tirelli U; Monfardini S G Ital Chemioter; 1991; 38(1-3):79-82. PubMed ID: 1365618 [No Abstract] [Full Text] [Related]
17. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services. AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227 [TBL] [Abstract][Full Text] [Related]
18. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient. Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201 [No Abstract] [Full Text] [Related]
19. Jekyll and Hyde: a new license for thalidomide? Saphir A J Natl Cancer Inst; 1997 Oct; 89(20):1480-1. PubMed ID: 9337341 [No Abstract] [Full Text] [Related]
20. Doxil receives FDA market clearance. AIDS Patient Care STDS; 1996 Apr; 10(2):135. PubMed ID: 11361702 [No Abstract] [Full Text] [Related] [Next] [New Search]